News from perrigo company

( NASDAQ-NMS:PRGO,TelAviv:PRGO)

Jul 08, 2014, 08:47 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg

Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for...

May 30, 2014, 08:09 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc To Present At Jefferies 2014 Global Healthcare Conference

Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Jefferies 2014...

May 12, 2014, 09:23 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray

 Perrigo Company plc (NYSE: PRGO;TASE) announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its...

May 07, 2014, 08:00 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Reports Record Quarterly Revenue and Adjusted Operating Income Despite Weak Retail and Cough, Cold and Flu Seasons

  - Fiscal third quarter net sales increased 9% year-over-year to a record $1,004 million. - Fiscal third quarter adjusted net...

Apr 28, 2014, 14:30 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Quarterly Dividend

Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on...

Apr 23, 2014, 09:14 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc To Release Third Quarter Fiscal Year 2014 Results On May 7, 2014

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its third quarter fiscal year 2014 on...

Apr 01, 2014, 08:16 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces Launch Of Authorized Generic Version Of Taclonex® Ointment (Calcipotriene 0.005% / Betamethasone Dipropionate 0.064%)

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has initiated market launch and made its first shipments of the authorized generic...

Mar 26, 2014, 09:40 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Partners With Division Of Golden State Foods To Manufacture Store Brand Versions Of Ensure® Adult Nutritional Drinks

 Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Nutritionals segment is partnering with KanPak LLC to manufacture store...

Mar 12, 2014, 08:43 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces Launch Of Generic Version Of Neptazane™ (Methazolamide) Tablets

Perrigo Company (NYSE: PRGO; TASE) today announced that it has launched, through a distribution and supply agreement, methazolamide tablets, the...

Feb 28, 2014, 07:13 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Acquisition Of OTC Products In Australia

 Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand...

Feb 28, 2014, 07:13 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces The Transfer Of Development Asset ELND005 To Transition Therapeutics Inc.

 Perrigo Company plc (NYSE: PRGO; TASE) announced today that it entered into a series of agreements with existing collaboration partner,...

Feb 19, 2014, 10:57 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc To Present At Upcoming Healthcare Conference

Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the RBC...

Feb 06, 2014, 08:03 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Reports Record Revenue, Adjusted Earnings and Margins

- Fiscal second quarter net sales increased 11% year-over-year to a record $979 million. - Fiscal second quarter adjusted net...

Jan 29, 2014, 11:20 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Quarterly Dividend

 Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable...

Jan 23, 2014, 09:41 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc to Release Second Quarter Fiscal Year 2014 Results on February 6, 2014

 Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter fiscal year 2014 on...

Jan 14, 2014, 14:57 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces FDA Final Approval for Generic Version of Vanos® (Fluocinonide) Cream 0.1%

 Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application ("ANDA") for...

Dec 18, 2013, 14:10 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Names Board of Directors

 Perrigo Company plc (NYSE: PRGO) today announced the appointment of its Board of Directors, effective until Perrigo Company's annual general...

Dec 13, 2013, 07:56 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company And Elan Corporation plc Receive Irish High Court Approval For Perrigo's Proposed Acquisition Of Elan

 Perrigo Company (NYSE: PRGO; TASE) and Elan Corporation, plc (NYSE: ELN) ("Elan") today announced that the Irish High Court has approved...

Nov 21, 2013, 08:00 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company Announces Receipt of Requisite Consents for and Pricing of Its Previously Announced Tender Offer and Consent Solicitation for its 2.950% Notes due 2023

 Perrigo Company (NYSE, TASE: PRGO) today announced that, in connection with its offer to purchase for cash (the "Tender Offer") any and all...

Nov 20, 2013, 11:22 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Confirms Filing For Generic Version Of Acanya

 Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer